Open original FDA record ↗Recall record
- FDA identifier
- Z-2795-2015
- Company in FDA record
- Brainlab AG
- FDA record creation date
- Nov 11, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Disposable Reflective Marker Spheres (DRMS) for Brainlab Image Guided Surgery (IGS) Systems: DRMS spheres may separate at the mid-point where the two halves of the sphere are sealed together.
Source facts
- Action
- The firm, Brainlab AG, sent out a" FIELD SAFETY NOTICE/ PRODUCT NOTIFICATION" dated 7/23/2015 to its customers. The firm sent this letter to mitigate the potential effects of the affected Disposable Reflective Marker Spheres (DRMS) when used with Brainlab Image Guided Surgery (IGS) systems. The firm advised the medical users that they should take the following steps prior to each procedure using Brainlab DRMS spheres for Brainlab IGS systems: -Prior to opening the package containing the spheres, visually inspect the spheres in the blister pack for any signs of separation between the two halves of the sphere. If there is any indication that the spheres may have separated, use a different blister pack for the procedure and repeat this step with the new pack. Discard any and all affected spheres and inform your Brainlab support representative about the occurrence of the issue. If there is no visual sign of sphere separation, proceed to the next step. -Prior to the start of the procedure, screw each DRMS sphere onto the tool and tighten. Upon tightening, inspect again to determine whether any separation between the two halves is evident. If separation is evident, remove and discard the affected sphere. Replace your surgical gloves, then replace the separated sphere with a new sphere, inspecting it as above. If no separation is evident, proceed with the clinical procedure. -Be sure to discard and replace your surgical gloves any time that a sphere with evident separation is found upon affixing the sphere to the tool, and every time after a separated sphere was touched. -Caution: Do not affix the sphere to the tool over the surgical area to minimize the risk of a sphere, or any portion thereof, falling onto the patient or into the surgical wound. Also avoid affixing the sphere over other sterile areas (such as surgical trays) to minimize potential contamination in case of sphere separation. -Reminder: In general, do not use defective or deformed marker
- Initiated
- 2015-08-18
- Root cause
- Process control
- Terminated
- 2017-01-05
- Distribution
- Worldwide Distribution: US (nationwide) including states of: TX, CA, TN, NY, LA, IL, MA, PA, OH, AZ, ID, CT, MI, and KY; and countries of: Algeria, Argentina, Australia, Bahrain, Belarus, Bolivia, Brazil, Chile, China, Colombia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Finland, France, Germany, Hong Kong, Hungary, India, Iran, Iraq, Ireland, Israel, Italy, Japan, Kazakhstan, Korea, Kuwait, Libya, Lithuania, Malaysia, Malta, Mexico, Moldova, Morocco, Myanmar, Netherlands, Philippines, Poland, Portugal, Puerto Rico, Qatar, Russian Federation, Saudi Arabia, Singapore, Slovenia, South Africa, Switzerland, Taiwan, Thailand, Turkey, Ukraine, United Arab Emirates, United Kingdom, , Venezuela, and Vietnam.
- Recall number
- Z-2795-2015
- Recall status
- Terminated
- CDRH record ID
- 139559
- FDA record created
- 2015-11-11
- Recall event number
- 71996